📊 This is a company profile preview from Tablestat.com Request a Free Trial Now

Company profile: ESBATech

1.1 - Company Overview

ESBATech Logo

ESBATech

Headquarter: Switzerland
Founded: 20XX🔒
Employees: 100-500🔒

Company description

  • Provider of fully human antibody fragments for therapeutic applications, leveraging proprietary, fully human single-chain antibody frameworks to generate product candidates against clinically relevant targets.

Products and services

🔒

Key contacts

🔒
🔒

Financial details

🔒

1.2 - Competitors and similar companies to ESBATech

TG Therapeutics Logo

TG Therapeutics

HQ: United States Website
  • Description: Provider of biopharmaceutical therapies for hematologic malignancies and autoimmune disorders, including BRIUMVI, a treatment for relapsing forms of multiple sclerosis—clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease—in adults.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full TG Therapeutics company profile →
Faron Pharmaceuticals Logo

Faron Pharmaceuticals

HQ: Finland Website
  • Description: Provider of clinical-stage biopharmaceutical therapies targeting acute organ trauma, vascular damage, and cancer immunotherapy, including bexmarilimab, a humanized monoclonal antibody against Clever-1 on macrophages to modify the tumor microenvironment and boost anti-tumor immune response, and Traumakine, an intravenous interferon beta-1a to prevent multiorgan dysfunction and mitigate CAR-T side effects (cytokine release syndrome, neurotoxicity).
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Faron Pharmaceuticals company profile →
xCella Biosciences Logo

xCella Biosciences

HQ: United States Website
  • Description: Provider of antibody discovery technologies, offering a platform to screen single B cells and develop therapeutics via protein engineering. Products include the OmniAb Discovery Platform and transgenic animal systems: OmniRat, OmniMouse, OmniChicken for generating fully human antibodies; OmniFlic and OmniClic for bispecific discovery; and xPloration integrated hardware/software for high-dimensional measurement and analysis.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full xCella Biosciences company profile →
Kairos Therapeutics Logo

Kairos Therapeutics

HQ: Canada Website
  • Description: Provider of a proprietary next-generation antibody-drug conjugate platform as a biopharmaceutical company.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Kairos Therapeutics company profile →
Delenex Therapeutics Logo

Delenex Therapeutics

HQ: Switzerland Website
  • Description: Provider of therapeutic antibody fragments targeting serious medical diseases with high unmet need, designed for local/topical application to deliver the benefits of antibody therapy with limited systemic exposure, built on clinically validated technology.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Delenex Therapeutics company profile →
🔒

2.M&A buyers

2.1 Potential strategic acquirers in the sector

🔒
🔒
🔒
🔒 View all strategic buyers with complete profiles
Start Free Trial →

2.2 - Strategic buyer groups for ESBATech

🔒

Buyer group 1: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 2: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 3: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →

3. Investors and private equity firms

3.1 - Buyout funds investing in similar companies to ESBATech

2.2 - Growth funds investing in similar companies to ESBATech

🔒 View all growth equity funds with complete profiles
Start Free Trial →

4 - Top valuation comps for ESBATech

4.2 - Public trading comparable groups for ESBATech

🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →

4.3 - M&A Transactions similar to ESBATech

Selected M&A transactions

Date Target Description Buyer(s) Relevance EV EV/Revenue EV/EBITDA
🔒 View all M&A transactions with complete deal terms
Request Free Trial Now →

Frequently Asked Questions

About ESBATech

What does ESBATech do?

ESBATech is a provider of fully human antibody fragments for therapeutic applications, leveraging proprietary, fully human single-chain antibody frameworks to generate product candidates against clinically relevant targets.

Who are ESBATech's competitors?

ESBATech's competitors and similar companies include TG Therapeutics, Faron Pharmaceuticals, xCella Biosciences, Kairos Therapeutics, and Delenex Therapeutics.

Where is ESBATech headquartered?

ESBATech is headquartered in Switzerland.

How many employees does ESBATech have?

ESBATech has 1,000 employees 🔒.

When was ESBATech founded?

ESBATech was founded in 2010 🔒.

What sector and industry vertical is ESBATech in?

ESBATech is in the Enterprise Software 🔒 sector and industry

M&A Buyers & Acquirers for ESBATech

Who are the top strategic acquirers in ESBATech's sector and industry

Top strategic M&A buyers and acquirers in ESBATech's sector include ████████, ██████████, ██████, ████████, and ██████████ 🔒.

Which M&A buyer groups are most relevant for ESBATech?

Top strategic M&A buyers groups and sectors for ESBATech include █████████████████ , ████████████████, █████████████, ████████████, and ████████████████ 🔒.

Financial Investors investing in ESBATech's sector and industry vertical

Which are the top PE firms investing in ESBATech's sector and industry vertical?

Top PE firms investing in ESBATech's sector and industry vertical include ████████, ██████████, ████████, and ██████████ 🔒.

Who are the top buyout funds acquiring in ESBATech's sector and industry vertical?

Active PE funds and buyout funds acquiring companies in ESBATech's sector and industry vertical include █████████, ██████████, ████████████, and ████████████ 🔒.

Who are the top growth equity funds investing in companies in ESBATech's sector and industry vertical?

Growth funds and venture capital funds investing in companies similar to ESBATech include █████████, ██████████, ████████████, and ████████████ 🔒.

Valuation benchmarks of companies in ESBATech's sector and industry

Which are the key public companies that are relevant trading comps benchmarks for ESBATech?

The key public trading comparables and valuation benchmarks for ESBATech include █████████, ██████████, ████████████, and ████████████ 🔒.

Which are the key trading comparable groups for ESBATech for public valuation benchmarks?

Our platform tracks detailed public trading comparable groups and valuation benchmarks for ESBATech with complete valuation multiples, growth metrics, and profitability data. Access the full database to benchmark your company against relevant public comparables.

What are recent M&A transactions in ESBATech's sector and industry vertical?

Our platform tracks relevant M&A transactions comparables and valuation benchmarks for ESBATech with complete deal terms, valuation multiples, and strategic rationale. Access the full database to benchmark pricing and identify active acquirers.

What are recent capital raises and funding rounds in ESBATech's' sector and industry vertical?

Access recent funding rounds and capital raises in ESBATech's sector and industry vertical including growth equity, venture capital, and buyout investments. Our database includes round size, lead investors and valuations.

Ready to Find the Right Buyers?

Access complete buyer lists, valuation data, and M&A intelligence for ESBATech